This effect is exerted, in part, by an autocrine loop in which fibulin-3 activates NF-κB–mediated transcription in GBM cells to increase their expression of signals that modify TAM behavior, such as CSF-1, TGF-β1, and the phagocytosis inhibitor CD47. This evidence concerns the gene EFEMP1 and glioblastoma.